Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Becker

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2024
Real-world experience in initiation of treatment with the selective cardiomyosin inhibitor mavacamten in an outpatient clinic cohort during the 12-week titration periodFinn Becker, Julia Novotny, Nadine Jansen, et al.
Depression and Anxiety|April 22, 2025
Symptoms of Depression and Anxiety After COVID-19 Despite Systematic Telemedical Care: Results From the Prospective COVID-SMART StudyAenne S von Falkenhausen, Antonia Gail, Scott Geipel, et al.
Urologic Oncology|June 21, 2022
Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarkerFinn Becker, Anne Offermann, Marie C Roesch, et al.
Human Pathology|July 27, 2021
CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasiaAnne Offermann, Vincent Joerg, Marie C Hupe, et al.
Carcinogenesis|May 5, 2022
Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissueFinn-Ole Paulsen, Duan Kang, Finn Becker, et al.
International Journal of Cancer|July 5, 2019
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancerFinn Becker, Vincent Joerg, Marie C Hupe, et al.
The American Journal of Cardiology|November 29, 2024
Progress of Angiographic Cardiac Allograft Vasculopathy in Patients With Long-Term Transplantation: Longitudinal Evaluation of Its Association With Dyslipidemia PatternsDavid Grundmann, Janina Neubarth-Mayer, Christoph Müller, et al.
The American Journal of Pathology|February 19, 2022
Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate CancerAnne Offermann, Vincent Joerg, Finn Becker, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
Frontiers in Oncology|January 9, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial DiagnosisMarie Christine Hupe, Christian Philippi, Doris Roth, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2024
Real-world experience in initiation of treatment with the selective cardiomyosin inhibitor mavacamten in an outpatient clinic cohort during the 12-week titration periodFinn Becker, Julia Novotny, Nadine Jansen, et al.
Depression and Anxiety|April 22, 2025
Symptoms of Depression and Anxiety After COVID-19 Despite Systematic Telemedical Care: Results From the Prospective COVID-SMART StudyAenne S von Falkenhausen, Antonia Gail, Scott Geipel, et al.
Urologic Oncology|June 21, 2022
Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarkerFinn Becker, Anne Offermann, Marie C Roesch, et al.
Human Pathology|July 27, 2021
CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasiaAnne Offermann, Vincent Joerg, Marie C Hupe, et al.
Carcinogenesis|May 5, 2022
Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissueFinn-Ole Paulsen, Duan Kang, Finn Becker, et al.
International Journal of Cancer|July 5, 2019
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancerFinn Becker, Vincent Joerg, Marie C Hupe, et al.
The American Journal of Cardiology|November 29, 2024
Progress of Angiographic Cardiac Allograft Vasculopathy in Patients With Long-Term Transplantation: Longitudinal Evaluation of Its Association With Dyslipidemia PatternsDavid Grundmann, Janina Neubarth-Mayer, Christoph Müller, et al.
The American Journal of Pathology|February 19, 2022
Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate CancerAnne Offermann, Vincent Joerg, Finn Becker, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
Frontiers in Oncology|January 9, 2019
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial DiagnosisMarie Christine Hupe, Christian Philippi, Doris Roth, et al.
Pageof 2